Table 3.
Patients | |||||
---|---|---|---|---|---|
Follow-up | Patients | Improved | Patients | ||
Study | Patients | (mo) | Dry (%) | (%) | Failed (%) |
Politano83 | 51 | 6 | 26 (51) | 10 (20) | 15 (29) |
Lim et al49 | 28 | - | 6 (21) | 9 (33) | 13 (46) |
Schulman et al48 | 56 | 3 | 39 (70) | 9 (16) | 8 (14) |
Deane et al76 | 28 | 3–24 | 9 (32) | 8 (28) | 11 (40) |
Beckingham et al77 | 26 | 36 | 2 (7) | 7 (27) | 17 (66) |
Harrison et al78 | 36 | 61 | 4 (11) | 8 (22) | 24 (67) |
Lotenfoe et al79 | 21 | 11 | 8 (38) | 4 (19) | 9 (43) |
Lopez et al80 | 74 | 31 | 41 (56) | 15 (20) | 18 (24) |
Vesey et al81 | 36 | 9 (3–36) | 20 (56) | 4 (11) | 12 (33) |
Herschorn and Glazer46 | 46 | 12 | 14 (31) | 19 (41) | 13 (28) |